WARRANT
NUMBER


G
_______________


 


CARDAX,
INC.


 


WARRANT
TO PURCHASE SHARES OF COMMON STOCK


 


NEITHER
THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE UPON ITS EXERCISE HAVE BEEN REGISTERED UNDER EITHER THE SECURITIES ACT OF
1933, AS AMENDED (THE “SECURITIES ACT”) OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD, OFFERED FOR
SALE, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT WITH RESPECT TO SUCH
SECURITIES UNDER THE SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY
THAT SUCH REGISTRATION IS NOT REQUIRED.


 


THIS
CERTIFIES THAT, for value received,                                              
(together with its successors and assigns, the “Holder”), commencing July 19, 2019 (the “Date
of Issue”) is entitled to purchase, subject to the conditions set forth below, at any time and from time to time,
in whole or in part, during the Exercise Period (as defined in Section 1.3), that number of fully paid and non-assessable
shares (the “Shares”) of common stock, par value $0.001 per share (“Common Stock”),
of Cardax, Inc., a Delaware corporation (the “Company”), that is not more than the Warrant Share Number
(as defined in Section 1.1), subject to the further provisions of this warrant to purchase newly issued shares of Common
Stock (the “Warrant”), at the Warrant Exercise Price (as defined in Section 1.2), subject to
the further provisions of this Warrant.


 


1.
EXERCISE OF WARRANT


 


The
terms and conditions upon which this Warrant may be exercised, and the shares of Common Stock covered hereby which may be purchased
hereunder, are as follows:


 


1.1.
Warrant.


 


(a)
The Company hereby issues to the Holder this Warrant.


 




    	 



    	 



    

 


(b)
The number of Shares that the Holder is entitled to purchase under the terms and conditions of this Warrant (the “Warrant
Share Number”) is equal to 1,500,000 Shares.


 


(c)
For the purposes of this Agreement, the following terms shall have the respective meanings ascribed thereto in this Section
1.1(c):


 


(i)
“Affiliate” shall have the meaning ascribed to such term under the Securities Act and the regulations
promulgated thereunder.


 


(ii)
“Business Day” shall mean any date that the banks and the securities markets are in New York, New York
open for business for the conduct of business in the regular course on such date.


 


(iii)
“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.


 


(iv)
“Person” shall mean any individual, trust or entity or governmental authority or agency.


 


1.2.
The Warrant Exercise Price. The exercise price for the Warrant (the “Warrant Exercise Price”)
shall be equal, per share, to $0.12, subject to adjustment as provided in Section 4:


 


1.3.
Method of Exercise.


 


(a)
The Holder of this Warrant may exercise, in whole or in part, the purchase rights evidenced by this Warrant during the period
commencing on the Date of Issue of this Warrant and ending on July 19, 2024, unless extended by the Company in its sole discretion
(the “Exercise Period”). Such exercise shall be effected by:


 


(i)
the surrender of the Warrant, together with a duly executed copy of the form of subscription attached hereto (a “Notice
of Exercise”), to the Secretary of the Company at its principal offices;


 


(ii)
the payment to the Company, by certified check or bank draft payable to its order, of an amount equal to the aggregate Warrant
Exercise Price for the number of Shares for which the purchase rights hereunder are being exercised; and


 


(iii)
the delivery to the Company, if necessary, to assure compliance with federal and state securities laws, of an instrument executed
by the Holder certifying that the Shares are being acquired for the sole account of the Holder and not with a view to any resale
or distribution.


 




    	2



    	 



    

 


(b)
Conditions to Exercise of the Warrant.


 


(i)
Notwithstanding the provisions of any provision of this Warrant, including Section 1.3, the exercise of this Warrant is
contingent upon the Company’s satisfaction that the issuance of the Shares for which this Warrant is being exercised is
exempt from the requirements of the Securities Act and all applicable state securities laws or the Shares are duly registered
under the Securities Act. The Holder of this Warrant agrees to execute any and all documents deemed necessary by the Company to
effect the exercise of this Warrant.


 


(ii)
Notwithstanding anything to the contrary contained herein, the number of Shares that may be acquired by the Holder upon any exercise
of this Warrant (or otherwise in respect hereof) shall be limited to the extent necessary to insure that, following such exercise
(or other issuance), the total number of shares of Common Stock then beneficially owned by such Holder and its Affiliates and
any other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder’s for purposes of Section
13(d) of the Exchange Act (the “Beneficial Ownership”, does not exceed 4.99% of the total number of
issued and outstanding shares of Common Stock (including for such purpose the shares of Common Stock issuable upon such exercise)
(the “Maximum Percentage”). For the avoidance of doubt, except as otherwise provided herein in connection
with a transaction described in Section 4.3 (a “Fundamental Transaction”), this Warrant may not be exercised
in whole or in part if the Holder’s Beneficial Ownership (as calculated herein) exceeds the Maximum Percentage prior to
such exercise. For such purposes, “Beneficial Ownership” shall be determined in accordance with Section
13(d) of the Exchange Act and the rules and regulations promulgated thereunder. This provision shall not restrict the number of
shares of Common Stock which a Holder may receive or beneficially own in order to determine the amount of securities or other
consideration that such Holder may receive in the event of a Fundamental Transaction of this Warrant or under any other provision
of Section 4. This restriction may not be waived except by the Holder providing a notice to the Company as provided herein.
For any reason at any time, upon the written or oral request of the Holder, the Company shall promptly confirm in writing (which
may be by electronic mail) to the Holder the number of shares of Common Stock then outstanding. To the extent that the limitation
contained in this Section 1.3(b)(ii) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by such Holder together with any Affiliates) and of which a portion of this Warrant is exercisable shall
be in the sole discretion of a Holder, and the submission of a Notice of Exercise shall be deemed to be each Holder’s determination
of whether this Warrant is exercisable (in relation to other securities owned by such Holder together with any Affiliates) and
of which portion of this Warrant is exercisable, in each case subject to such aggregate percentage limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination other than its obligation in this Section
1.3(b)(ii) above to, upon the Holder’s request, confirm in writing to the Holder the number of shares of Common Stock
then outstanding. Notwithstanding any provision of this Section 1.3(b)(ii) to the contrary, the limitations on the exercise
of this Warrant under this Section 1.3(b)(ii) shall not be applicable from and after the date that is 61 days after the
date that the Holder provides written notice to the Company that the Holder elects to have Beneficial Ownership of the Company’s
Common Stock in excess of the Maximum Percentage, in which case such Holder shall have the right to exercise this Warrant without
the limitations of this Section 1.3(b)(ii); provided, that the limitations of this Section 1.3(b)(ii) shall
again be applicable to any assignee of this Warrant until 61 days after such assignee provides such notice to the Company.


 




    	3



    	 



    

 


1.4.
Issuance of Shares. In the event the purchase rights evidenced by this Warrant are exercised in whole or in part, one or
more certificates for the purchased Shares shall be issued as soon as practicable thereafter to the Holder.


 


1.5.
Partial Exercise. If this Warrant shall have been exercised only in part, then the Company shall, at the time of delivery
of the certificate or certificates for the Shares purchased upon such exercise, also deliver to the Holder a new Warrant evidencing
the remaining outstanding unexercised balance of Shares purchasable hereunder.


 


1.6.
Cancellation. Notwithstanding anything in this Warrant to the contrary, this Warrant shall be cancelled, and shall not
be exercisable, if it is not exercised before the expiration of the Exercise Period.


 


2.
TRANSFER RESTRICTIONS


 


2.1.
Transfer. This Warrant and the Shares issuable upon exercise hereof are “restricted securities” as such term
is defined by the rules and regulations promulgated under the Securities Act. This Warrant and the Shares issuable upon exercise
hereof may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of this Warrant
or the Shares issuable upon exercise hereof, other than pursuant to an effective registration statement or Rule 144, to the Company
or to an Affiliate of a Holder, the Company may require the transferor to provide to the Company an opinion of counsel selected
by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory
to the Company, to the effect that such transfer does not require registration of the transferred Warrant or Shares under the
Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Warrant
and the Agreement and shall have the rights and obligations of a Holder under this Warrant and the Agreement.


 


2.2.
Legend.


 


(a)
The Holder agrees to the imprinting of a legend on any of the Shares issuable upon exercise hereof in the following form:


 


THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY,
MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF
WHICH SHALL BE REASONABLY ACCEPTABLE TO THE CORPORATION. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED
IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.


 




    	4



    	 



    

 


(b)
Notwithstanding the foregoing, certificates evidencing this Warrant or the Shares issuable upon exercise hereof shall not contain
any legend (including the legend set forth above), (i) while a registration statement covering the resale of such security is
effective under the Securities Act, (ii) following any sale of this Warrant or such Shares issuable upon exercise hereof pursuant
to Rule 144, (iii) if this Warrant or such Shares issuable upon exercise hereof are eligible for sale under Rule 144, without
the requirement for the Company to be in compliance with the current public information required under Rule 144 as to this Warrant
or such Shares issuable upon exercise hereof and without volume or manner-of-sale restrictions, or (iv) if such legend is not
required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by
the staff of the Commission).


 


2.3.
Sale. The Holder agrees that the Holder will sell this Warrant or any Shares issuable upon exercise hereof only pursuant
to either: (i) the registration requirements of the Securities Act, including any applicable prospectus delivery requirements;
or (ii) an exemption therefrom, and that if this Warrant or any Shares issuable upon exercise hereof are sold pursuant to any
such effective registration statement, they will be sold in compliance with the plan of distribution set forth therein, and acknowledges
that the removal of the restrictive legend from certificates representing the Shares or this Warrant is predicated upon the Company’s
reliance upon this understanding.


 


3.
Fractional Shares


 


Notwithstanding
that the number of Shares purchasable upon the exercise of this Warrant may have been adjusted pursuant to the terms hereof, the
Company shall nonetheless not be required to issue fractions of Shares upon exercise of this Warrant or to distribute certificates
that evidence fractional shares, provided that in lieu of any fraction shares, the Company shall make a cash payment to the Holder
in an amount equal to the fair market value (as determined by the Board of Directors of the Company in its reasonable good faith)
of such fractional share.


 






    	5



    	 



    

 


4.
ANTIDILUTION PROVISIONS


 


4.1.
Stock Splits and Combinations. If the Company shall at any time subdivide or combine its outstanding shares of Common Stock,
this Warrant shall, after that subdivision or combination, evidence the right to purchase the number of shares of Common Stock
that would have been issuable as a result of that change with respect to the shares of Common Stock which were purchasable under
this Warrant immediately before that subdivision or combination. If the Company shall at any time subdivide the outstanding shares
of Common Stock, the Warrant Exercise Price then in effect immediately before that subdivision shall be proportionately decreased,
and, if the Company shall at any time combine the outstanding shares of Common Stock, the Warrant Exercise Price then in effect
immediately before that combination shall be proportionately increased. Any adjustment under this section shall become effective
at the close of business on the date the subdivision or combination becomes effective.


 


4.2.
Reclassification, Exchange and Substitution. If the Common Stock issuable upon exercise of this Warrant shall be changed
into the same or a different number of shares of any other class or classes of stock, whether by capital reorganization, reclassification,
or otherwise (other than a subdivision or combination of shares provided for above), the Holder of this Warrant shall, on its
exercise, be entitled to purchase for the same aggregate consideration, in lieu of the Common Stock that the Holder would have
been entitled to purchase but for such change, a number of shares of such other class or classes of stock equivalent to the number
of shares of Common Stock that would have been subject to purchase by the Holder on exercise of this Warrant immediately before
that change.


 


4.3.
Reorganizations, Mergers, Consolidations or Sale of Assets. If at any time there shall be a capital reorganization of the
Company’s Common Stock (other than a combination, reclassification, exchange, or subdivision of shares provided for elsewhere
above) or merger or consolidation of the Company with or into another entity, or the sale of the Company’s properties and
assets as, or substantially as, an entirety to any other person or entity, then, as a part of such reorganization, merger, consolidation
or sale, lawful provision shall be made so that the Holder of this Warrant shall thereafter be entitled to receive upon exercise
of this Warrant, during the period specified in this Warrant and upon payment of the Warrant Exercise Price then in effect, the
number of shares of Common Stock or other securities or property of the Company, or of the successor entity resulting from such
merger or consolidation, to which a holder of the Common Stock deliverable upon exercise of this Warrant would have been entitled
in such capital reorganization, merger, or consolidation or sale if this Warrant had been exercised immediately before that capital
reorganization, merger, consolidation, or sale. In any such case, appropriate adjustment (as determined in good faith by the Company’s
Board of Directors) shall be made in the application of the provisions of this Warrant with respect to the rights and interests
of the Holder of this Warrant after the reorganization, merger, consolidation, or sale to the end that the provisions of this
Warrant (including adjustment of the Warrant Exercise Price then in effect and number of Shares purchasable upon exercise of this
Warrant) shall be applicable after that event, as near as reasonably may be, in relation to any shares or other property deliverable
after that event upon exercise of this Warrant. The Company shall, within thirty (30) days after making such adjustment, give
written notice (by first class mail, postage prepaid) to the Holder of this Warrant at the address of the Holder shown on the
Company’s books. That notice shall set forth, in reasonable detail, the event requiring the adjustment and the method by
which the adjustment was calculated, and specify the Warrant Exercise Price then in effect after the adjustment and the increased
or decreased number of Shares or the other shares or property purchasable upon exercise of this Warrant. When appropriate, that
notice may be given in advance and include as part of the notice required under other provisions of this Warrant.


 




    	6



    	 



    

 


5.
Reservation of Stock Issuable Upon Exercise


 


The
Company shall at all times reserve and keep available out of its authorized but unissued shares of Common Stock solely for the
purpose of effecting the exercise of this Warrant such number of its shares of Common Stock as shall from time to time be sufficient
to effect the exercise of this Warrant and if at any time the number of authorized but unissued shares of Common Stock shall not
be sufficient to effect the exercise of this Warrant, in addition to such other remedies as shall be available to the Holder of
this Warrant, the Company will use its best efforts to take such corporate action as may, in the opinion of its counsel, be necessary
to increase its authorized but un-issued shares of Common Stock to such number of shares as shall be sufficient for such purposes.


 


6.
RIGHTS PRIOR TO EXERCISE OF WARRANT


 


6.1.
This Warrant does not entitle the Holder to any of the rights of a stockholder of the Company, including without limitation, the
right to receive dividends or other distributions, to exercise any preemptive rights, to vote, or to consent or to receive notice
as a stockholder of the Company. If, however, at any time prior to the termination of this Warrant and prior to its exercise,
any of the following events shall occur:


 


(a)
the Company shall declare any dividend payable in any securities upon its shares of Common Stock or make any distribution (other
than a regular cash dividend) to the Holders of its shares of Common Stock; or


 


(b)
the Company shall offer to the holders of its shares of Common Stock any additional Warrant of Common Stock or securities convertible
into or exchangeable for shares of Common Stock or any right to subscribe for or purchase any thereof; or


 


(c)
a dissolution, liquidation or winding up of the Company (other than in connection with a consolidation, merger, sale, transfer
or lease of all or substantially all of its property, assets and business as an entirety) shall be proposed and action by the
Company with respect thereto has been approved by the Company’s Board of Directors;


 


then
in any one or more of said events the Company shall give notice in writing of such event to the Holder at the last address of
the Holder as it shall appear on the Company’s records at least twenty (20) days prior to the date fixed as a record date
or the date of closing the transfer books for the determination of the stockholders entitled to such dividends, distribution,
or subscription rights, or for the determination of stockholders entitled to vote on such proposed dissolution, liquidation or
winding up. Such notice shall specify such record date or the date of closing the transfer books, as the case may be. Failure
to publish, mail or receive such notice or any defect therein or in the publication or mailing thereof shall not affect the validity
of any action taken in connection with such dividend, distribution or subscription rights, or such proposed dissolution, liquidation
or winding up. Each person in whose name any certificate for shares of Common Stock is to be issued shall for all purposes be
deemed to have become the holder of record of such shares on the date on which this instrument was surrendered and payment of
the Warrant Exercise Price was made, irrespective of the date of delivery of such stock certificate, except that, if the date
of such surrender and payment is a date when the stock transfer books of the Company are closed, such person shall be deemed to
have become the holder of such shares of Common Stock at the close of business on the next succeeding date on which the stock
transfer books are open.


 




    	7



    	 



    

 


7.
SUCCESSORS AND ASSIGNS


 


The
terms and provisions of this Warrant shall inure to the benefit of, and be binding upon, the Company and the Holder hereof and
their respective successors and permitted assigns.


 


8.
LOSS OR MUTILATION


 


8.1.
Upon receipt by the Company of satisfactory evidence of the ownership of and the loss, theft, destruction, or mutilation of any
Warrant, and (i) in the case of loss, theft, or destruction, upon receipt by the Company of indemnity satisfactory to it, or (ii)
in the case of mutilation, upon receipt of such Warrant and upon surrender and cancellation of such Warrant, the Company shall
execute and deliver in lieu thereof a new Warrant representing the right to purchase an equal number of shares of Common Stock.


 


8.2.
The Holder also acknowledges that each of the Shares issuable upon the due exercise hereof will be subject to any transfer restrictions
in the Company’s Articles of Incorporation, including a right of first refusal to the Company, and the certificate or certificates
evidencing the Shares will bear a legend to this effect.


 


9.
TERMINATION DATE


 


This
Warrant shall terminate upon the sooner of (a) the expiration of the Exercise Period; or (b) the exercise of all or any portion
of this Warrant pursuant to the terms of Section 1 hereof.


 


10.
GOVERNING LAW


 


This
Warrant and any dispute, disagreement or issue of construction or interpretation arising hereunder whether relating to its execution,
its validity, the obligations provided herein or performance shall be governed or interpreted according to the internal laws of
the State of New York without regard to conflicts of law.


 


11.
HEADINGS


 


The
headings and captions used in this Warrant are used only for convenience and are not to be considered in construing or interpreting
this Warrant. All references in this Warrant to sections and exhibits shall, unless otherwise provided, refer to sections hereof
and exhibits attached hereto, all of which exhibits are incorporated herein by this reference.


 


12.
AMENDMENTS


 


The
terms and conditions of this Warrant shall not be amended, modified or supplemented other than in accordance with a written amendment
signed by the Holder and the Company that specifically provides for such amendment, modification or supplement.


 




    	8



    	 



    

 


13.
NOTICES


 


All
notices or other communications given or made hereunder shall be in writing and shall be mailed by certified mail, delivered by
professional courier or hand, or transmitted via email or facsimile, to such party’s address as set forth in the Warrant
Register, or such other address as the Holder or the Company shall notify the other in writing as above provided. Any notice sent
in accordance with this section shall be effective on the date three days after the date of mailing or, if delivered by hand or
professional courier, or transmitted via email or facsimile with delivery receipt (or acknowledgement or confirmation which may
be by electronic means), on the date of delivery, provided, however, that notices to the Company will be effective upon receipt.


 


14.
SEVERABILITY


 


If
one or more provisions of this Warrant are held to be unenforceable under applicable law, such provision(s) shall be excluded
from this Warrant and the balance of this Warrant shall be interpreted as if such provision(s) were so excluded and shall be enforceable
in accordance with its terms.


 


15.
WARRANT REGISTER and OWNERSHIP


 


Each
Warrant issued by the Company shall be numbered and shall be registered in a warrant register (the “Warrant Register”)
as it is issued and transferred, which Warrant Register shall be maintained by the Company at its principal office or, at the
Company’s election and expense, by a Warrant Agent or the Company’s transfer agent. The Company shall be entitled
to treat the registered Holder of any Warrant on the Warrant Register as the owner in fact thereof and the Holder for all purposes
and shall not be bound to recognize any equitable or other claim to or interest in such Warrant on the part of any other Person,
and shall not be affected by any notice to the contrary, except that, if and when any Warrant is properly assigned in blank, the
Company may (but shall not be obligated to) treat the bearer thereof as the owner of such Warrant for all purposes. Subject to
Section 10, a Warrant, if properly assigned, may be exercised by a new holder without a new Warrant first having been issued.


 


16.
certain other provisions


 


16.1.
Any reference to an action or event to occur on a specified date that is not a Business Day shall be a reference to the immediately
following Business Day.


 


16.2.
Any calculations of the number of Shares to be issued upon the exercise of this Warrant, in whole or in part, shall be made by
the Company and, absent manifest error, such calculation shall be conclusive and binding.


 


[REMAINDER
OF THIS PAGE INTENTIONALLY LEFT BLANK. SIGNATURE PAGE FOLLOWS.]


 




    	9



    	 



    

 


In
Witness Whereof, the parties have executed
this Warrant as of the date first written above.


 


	 	COMPANY
	 	 
	 	CARDAX,
    INC.
	 	 
	 	By:	 
	 	Name:	 
	 	Title:	                       


 


	TRANSFER
    AGENT AND REGISTRAR	 
	 	 	 
	By:	 	 
	 	Authorized
    Signature	 


 




    	 



    	 



    

 


NOTICE
OF WARRANT EXERCISE


 


To:
Cardax, Inc.


2800
Woodlawn Drive, Suite 129


Honolulu,
HI 96822


 


Gentlemen:


 


The
undersigned,                                                                ,
hereby elects to purchase, pursuant to the provisions of the foregoing Warrant held by the undersigned,                  shares
of the common stock (“Common Stock”) of Cardax, Inc. Payment of the purchase price of __________ per
Share required under such Warrant accompanies this notice.


 


The
undersigned hereby represents and warrants that the undersigned is acquiring such Common Stock for the account of the undersigned
and not for resale or with a view to distribution of such Common Stock or any part hereof; that the undersigned is fully aware
of the transfer restrictions affecting restricted securities under the pertinent securities laws and the undersigned understands
that the shares purchased hereby are restricted securities and that the certificate or certificates evidencing the same will bear
a legend to that effect.


 


By
its delivery of this Notice of Warrant Exercise, the undersigned represents and warrants to the Company that (unless indicated
below) in giving effect to the exercise evidenced hereby the Holder will not beneficially own in excess of the number of shares
of Common Stock (determined in accordance with Section 13(d) of the Securities Exchange Act of 1934) permitted to be owned under
Section 1.3(b)(ii) of this Warrant to which this notice relates.


 


If
the number of shares of Common Stock purchased (and/or canceled) hereby is less than the number of shares of Common Stock covered
by the Warrant, the undersigned requests that a new Warrant representing the number of shares of Common Stock not so purchased
(or canceled) be issued and delivered as follows:


 


	ISSUE
    TO:	 	 
	 	(NAME
    OF HOLDER)	 
	 	 	 
	 	 	 
	 	(ADDRESS,
    INCLUDING ZIP CODE)	 
	 	 	 
	 	 	 
	 	(SOCIAL
    SECURITY OR OTHER IDENTIFYING NUMBER)	 


 


	DELIVER TO:	 
	 	 
	 	 	 
	 	(NAME)	 
	 	 	 
	 	 	 
	 	(ADDRESS,
    INCLUDING ZIP CODE)	 


 





DATED:
___________, ___.


	Signature:	 	 
	 	 	 
	Name:	 	 
	 	 	 
	Title:	 	 
	 	 	 
	Address:
    	 	 
	 	 	 
	 	 	 


 




    	 



    	 



    

 


ASSIGNMENT
FORM


 


(To
assign the foregoing warrant, execute


this
form and supply required information.


Do
not use this form to exercise the warrant.)


 


FOR
VALUE RECEIVED, [               ] all of or
[               ] shares of the foregoing Warrant
and all rights evidenced thereby are hereby assigned to


 


_______________________________________________
whose address is


 


_______________________________________________________________


 


_______________________________________________________________


 


                                       
     Dated: ______________, _______


 


                    Holder’s
Signature: _____________________________


 


                    Holder’s
Address: _____________________________


 


Signature
Guaranteed: ___________________________________________


 


NOTE:
The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration
or enlargement or any change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those
acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.